Effects of combination lipid therapy in type 2 diabetes mellitus - The New England Journal of Medicine – 2010
Brief Summary:
Among adults with T2DM on statin monotherapy, the addition of fenofibrate does not reduce CVD endpoints.Reference: http://www.ncbi.nlm.nih.gov/pubmed/20228404
Comments
Post a Comment
Drop your thoughts here, we would love to hear from you